Bank of America’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.08M Buy
296,150
+35,220
+13% +$842K ﹤0.01% 3027
2025
Q1
$6.48M Buy
260,930
+123,733
+90% +$3.07M ﹤0.01% 3012
2024
Q4
$2.58M Sell
137,197
-104,942
-43% -$1.98M ﹤0.01% 3565
2024
Q3
$3.64M Sell
242,139
-316,848
-57% -$4.77M ﹤0.01% 3425
2024
Q2
$16M Sell
558,987
-40,412
-7% -$1.16M ﹤0.01% 2164
2024
Q1
$17.5M Buy
599,399
+144,184
+32% +$4.21M ﹤0.01% 2094
2023
Q4
$15.4M Buy
455,215
+128,327
+39% +$4.33M ﹤0.01% 2025
2023
Q3
$10M Buy
326,888
+142,487
+77% +$4.37M ﹤0.01% 2294
2023
Q2
$7.39M Sell
184,401
-41,641
-18% -$1.67M ﹤0.01% 2559
2023
Q1
$9.22M Buy
226,042
+47,975
+27% +$1.96M ﹤0.01% 2487
2022
Q4
$6.88M Sell
178,067
-16,106
-8% -$622K ﹤0.01% 2612
2022
Q3
$10.3M Sell
194,173
-27,647
-12% -$1.47M ﹤0.01% 2187
2022
Q2
$12.9M Buy
221,820
+27,769
+14% +$1.62M ﹤0.01% 2092
2022
Q1
$14.8M Buy
194,051
+3,557
+2% +$271K ﹤0.01% 2138
2021
Q4
$11.5M Sell
190,494
-9,985
-5% -$601K ﹤0.01% 2387
2021
Q3
$11.2M Buy
200,479
+18,461
+10% +$1.03M ﹤0.01% 2365
2021
Q2
$11M Sell
182,018
-12,874
-7% -$781K ﹤0.01% 2379
2021
Q1
$13.7M Buy
194,892
+46,937
+32% +$3.29M ﹤0.01% 2149
2020
Q4
$8.85M Sell
147,955
-6,415
-4% -$384K ﹤0.01% 2255
2020
Q3
$9.28M Sell
154,370
-7,028
-4% -$423K ﹤0.01% 2084
2020
Q2
$8.47M Sell
161,398
-20,760
-11% -$1.09M ﹤0.01% 2116
2020
Q1
$6.11M Buy
182,158
+56,232
+45% +$1.89M ﹤0.01% 2207
2019
Q4
$5.71M Buy
125,926
+1,120
+0.9% +$50.7K ﹤0.01% 2668
2019
Q3
$4.75M Sell
124,806
-8,558
-6% -$326K ﹤0.01% 2786
2019
Q2
$5.8M Sell
133,364
-95,413
-42% -$4.15M ﹤0.01% 2634
2019
Q1
$8.71M Buy
228,777
+7,205
+3% +$274K ﹤0.01% 2278
2018
Q4
$9.53M Sell
221,572
-13,619
-6% -$586K ﹤0.01% 2031
2018
Q3
$11.6M Buy
235,191
+42,690
+22% +$2.1M ﹤0.01% 2035
2018
Q2
$6.17M Sell
192,501
-3,437
-2% -$110K ﹤0.01% 2545
2018
Q1
$6.1M Buy
195,938
+12,258
+7% +$382K ﹤0.01% 2529
2017
Q4
$8.39M Buy
183,680
+9,741
+6% +$445K ﹤0.01% 2250
2017
Q3
$6.53M Sell
173,939
-11,497
-6% -$432K ﹤0.01% 2546
2017
Q2
$8.85M Buy
185,436
+68,021
+58% +$3.24M ﹤0.01% 2159
2017
Q1
$5.35M Sell
117,415
-315,778
-73% -$14.4M ﹤0.01% 2531
2016
Q4
$14M Buy
433,193
+355,526
+458% +$11.5M ﹤0.01% 1704
2016
Q3
$2.66M Sell
77,667
-49,628
-39% -$1.7M ﹤0.01% 2895
2016
Q2
$4.29M Buy
127,295
+27,607
+28% +$931K ﹤0.01% 2457
2016
Q1
$5.28M Sell
99,688
-28,635
-22% -$1.52M ﹤0.01% 2283
2015
Q4
$9.85M Sell
128,323
-161,199
-56% -$12.4M ﹤0.01% 1848
2015
Q3
$11.9M Buy
289,522
+246,432
+572% +$10.1M ﹤0.01% 1695
2015
Q2
$3.05M Sell
43,090
-7,940
-16% -$562K ﹤0.01% 2414
2015
Q1
$4.53M Sell
51,030
-83,757
-62% -$7.44M ﹤0.01% 2032
2014
Q4
$11.9M Buy
134,787
+38,859
+41% +$3.44M ﹤0.01% 1374
2014
Q3
$9.3M Buy
95,928
+22,079
+30% +$2.14M ﹤0.01% 1556
2014
Q2
$6.78M Buy
73,849
+70,403
+2,043% +$6.47M ﹤0.01% 1763
2014
Q1
$241K Sell
3,446
-17,138
-83% -$1.2M ﹤0.01% 4008
2013
Q4
$1.18M Buy
20,584
+18,949
+1,159% +$1.09M ﹤0.01% 2982
2013
Q3
$79K Sell
1,635
-16,500
-91% -$797K ﹤0.01% 4533
2013
Q2
$526K Buy
+18,135
New +$526K ﹤0.01% 3669